AzTrials
AzTrials

SLAP LesionBlast2NCT06772103

Biceps Tenodesis With 360 Suture Anchor Versus Self Locking Tenodesis In the Absence of Rotator Cuff Tears

A study testing self-locking biceps tenodesis and Biceps Tenodesis with 360 Suture anchor in people with SLAP Lesion, run by Clinique Générale dAnnecy at 1 site in France.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

This is a prospective randomized controlled trial. The aim of this study is to compare the clinical results and complications of self-locking biceps tenodesis and double-loop 360 lasso biceps tenodesis for the treatment of pathology of the long head of the biceps or superior labrum anterior-posterior (SLAP) during… Read more about this study

Who is it for?
Ages 40 years and older
Conditions the study is for
SLAP Lesion
What is being tested?
self-locking biceps tenodesis and Biceps Tenodesis with 360 Suture anchor
Type of treatment
Surgery or procedure
Could I receive a placebo?
No, everyone receives an active treatment
How many people
98 participants
Where
1 siteFrance
Study dates
22 Jan 2025to 1 Jan 2030
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 40 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Pathology of the LHBT or SLAP-type lesion based on clinical symptoms
  • Partial-thickness rupture or absence of full-thickness rupture of the rotator cuff of the subscapular, supraspinatus and/or infraspinatus tendons, diagnosed preoperatively on ultrasound, arthro-CT or MRI

Who cannot join

  • Full-thickness tears of the rotator cuff diagnosed preoperatively on ultrasound, arthro-CT or MRI.
  • Osteoarthritis of the glenohumeral joint, defined by narrowing of the glenohumeral joint space or osteophytes, using AP radiography of the affected shoulder.
  • Previous surgery on the affected shoulder
  • Patients presenting with motor paralysis of the shoulder
  • Preoperative presence of the Popeye sign or documented LHBT rupture
  • Dementia or inability to complete questionnaires and assessments in French or English.
Show all 9Show fewer
  • Pregnant or breast-feeding patient
  • Protected adult patient
  • Patient not covered by social security.

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Geert Alexander Buijze, MD contact

+33 669962733

gabuijze@hotmail.com

France1 site, 1 recruiting
  • Clinique Générale

    Annecy, 74000

    Recruiting

Other trials in France

About this study

Official title: Biceps Tenodesis With 360 Suture Anchor Versus Self-Locking Tenodesis in the Absence of Full-thickness Rotator Cuff Tears: Protocol for a Non-inferiority Randomized Controlled Trial (BLAST-2)

This is a prospective randomized controlled trial. The aim of this study is to compare the clinical results and complications of self-locking biceps tenodesis and double-loop 360 lasso biceps tenodesis for the treatment of pathology of the long head of the biceps or superior labrum anterior-posterior (SLAP) during shoulder arthroscopy in patients without arthroscopic rotator cuff tears. Currently, there is no consensus on the use of tenodesis versus tenotomy to treat pathology of the long head of the biceps during arthroscopic rotator cuff repair. Numerous studies have examined the clinical results of long biceps tenotomy versus long biceps tenodesis, and there is no evidence to date of superiority of either technique. However, these studies were carried out on patients with rotator cuff tears, and so it has not been possible to directly compare the two procedures. At Clinique Générale, we use a new, innovative technique called autobloc tenodesis to treat pathologies of the long head of the biceps. There are no comparative studies between autobloc tenodesis of the biceps and biceps tenodesis in patients without rotator cuff tears. Given its potential advantages, autobloc biceps tenodesis could become the new technique of choice for treating biceps longus tendon pathology, potentially reducing differences in outcomes such as Popeye deformity. The information provided by this study could potentially guide future clinical practice, helping surgeons choose the most appropriate treatment for their patients with long biceps tendon pathology.

Conditions
SLAP Lesion
Being tested
self-locking biceps tenodesis, Biceps Tenodesis with 360 Suture anchor
Keywords
biceps, tenodesis, imaging, tendon repair

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • self-locking biceps tenodesisProcedure or surgery

    The LHB tendon is detached from its origin at the level of the superior labrum. This technique supports the self-locking mechanism of the LHB tendon in the bicipital groove by detaching the tendon from the Y-shaped superior glenoid, including the superior labrum. A radiographically visible suture will be attached to the proximal part of the LHB tendon to facilitate subsequent localization of the LHB tendon during imaging (3-0 stainless steel, ethicon).

  • Biceps Tenodesis with 360 Suture anchorProcedure or surgery

    The LHB tendon is detached from its origin and sutured. Next, the LHB tendon is fixed in the bicipital groove using a 360-loop tenodesis technique with the Knotless FiberTak® biceps implant system. A radiographically visible suture will be attached to the proximal part of the LHB tendon to facilitate subsequent localization of the LHB tendon during imaging (3-0 stainless steel, ethicon).

Study groups in NCT06772103
Study groupRoleWhat they receive
self-locking biceps tenodesisExperimentalNot described
Receives: Procedure: self-locking biceps tenodesis
360° double-loop lasso biceps tenodesisActive comparatorNot described
Receives: Procedure: Biceps Tenodesis with 360 Suture anchor

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Constant score

    100-point scale comprising four components, including a patient-reported section (pain 15 points and activity level 20 points), for a total of 35 points. Alongside this is a doctor-reported section (shoulder strength 25 points, range of motion 40 points) for a total of 65 points.

    Measured: 1 year after surgery

Secondary outcomes (7)
  1. American Shoulder and Elbow Surgeons Score (ASES)

    The ASES is a 100-point scale comprising 2 assessment dimensions: pain and activities of daily living.

    Measured: 6 weeks, 3 months, 6 months, 1 year after surgery

  2. Subjective Shoulder Value (SSV)

    The SSV is a single-question assessment of the patient's perceived shoulder function expressed as a percentage of normal.

    Measured: 6 weeks, 3 months, 6 months, 1 year after surgery

  3. LHB score

    The LHB score assesses symptoms and function related to long head of the biceps tendon pathology.

    Measured: 6 months, 1 year after surgery

  4. cosmetic appearance

    Cosmetic appearance will be assessed by both the patient and the clinician using standardized photographs.

    Measured: 6 weeks, 3 months, 6 months, 1 year after surgery

  5. VAS pain score

    Pain intensity will be assessed using a visual analogue scale (VAS) at rest, during activity, and over the bicipital groove.

    Measured: 6 weeks, 3 months, 6 months, 1 year after surgery

  6. Radiograph

    Standardized radiographs will assess postoperative migration of the long head of the biceps tendon using a radio-opaque marker.

    Measured: Direct post-op, 6 weeks, 3 months, 6 months after surgery

  7. MRI or Ultra-sound

    MRI or ultrasound will assess the postoperative position of the long head of the biceps tendon at final follow-up.

    Measured: 1 year after surgery

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted13 Jan 2025
  2. Study start22 Jan 2025
  3. Primary completion1 Jan 2030 (estimated)
  4. Study completion1 Jan 2030 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Participant
Enrolment
98 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06772103
Sponsor's protocol ID
2024-43-CGA
Acronym
Blast2
Status last verified
Jul 2026
First submitted
8 Jan 2025
Last updated
9 Jul 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Publications

  • Boulidam D, Shirinskiy IJ, Macken AA, Van Den Bekerom MPJ, Lafosse T, Buijze GA. Biceps tenodesis with 360 degrees suture anchor versus self-locking tenodesis in the absence of full-thickness rotator cuff tears: protocol for a non-inferiority randomised controlled trial (BLAST-2). BMJ Open. 2026 Aug 4;16(8):e120296. doi: 10.1136/bmjopen-2026-120296.

    PubMed 42552012

Questions about this trial

What is this clinical trial studying?

A study testing self-locking biceps tenodesis and Biceps Tenodesis with 360 Suture anchor in people with SLAP Lesion, run by Clinique Générale dAnnecy at 1 site in France.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 9 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 9 Jul 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in France. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Geert Alexander Buijze, MD (+33 669962733, gabuijze@hotmail.com), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Constant score (time frame: 1 year after surgery). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT06772103, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 9 Jul 2026.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in